Why the study?
Purpura fulminans is a rarely encountered rapidly evolving ischemic dermatological emergency that has rarely been documented secondary to vasopressin.
Population
One 55-year-old male admitted to the ICU for DKA and septic shock
Design
Case report
Key result
Vasopressin administration for refractory septic shock induced a rapid development of purpura fulminans within one day, which improved upon discontinuation of the drug.
Authors
Loading...
Vasopressin may trigger purpura fulminans in septic shock; hypothesis-generating case leaves association unconfirmed.
Case Report (n=1)
No
Vasopressin use in septic shock may rarely be associated with the rapid development of purpura fulminans.
Awad et al. (2023) conducted a case report in Purpura fulminans (n=1). Vasopressin was evaluated on Development and resolution of purpura fulminans. Vasopressin administration for refractory septic shock induced a rapid development of purpura fulminans within one day, which improved upon discontinuation of the drug.